You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (19)

Journals (0)

1-10 of 19 results for Zanubrutinib

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: A fatal disseminated cryptococcal infection in a patient treated with zanubrutinib for Waldenström’s macroglobulinemia

Retricted access

Case report

First published 2022-12

A fatal disseminated cryptococcal infection in a patient treated with zanubrutinib for Waldenström’s macroglobulinemia

Dave Patel, Megan Sidana, Xolani Mdluli [...]

Journal of Oncology Pharmacy Practice

Select article: Nonclinical Safety Assessment of Zanubrutinib: A Novel Irreversible BTK Inhibitor

Free access

Research article

First published 2020-5

Nonclinical Safety Assessment of Zanubrutinib: A Novel Irreversible BTK Inhibitor

Cuining Zhang, Baohong Tian

International Journal of Toxicology

Select article: Zanubrutinib in lymphoproliferative disorders: a comprehensive review

Open access

Review article

First published 2022

Zanubrutinib in lymphoproliferative disorders: a comprehensive review

Javier Muñoz, Yucai Wang, Preetesh Jain [...]

Therapeutic Advances in Hematology

Select article: Clinician Perspective on Once-Daily Zanubrutinib Dosing for B-Cell Malignancies at a Single Center

Open access

Review article

First published 2024

Clinician Perspective on Once-Daily Zanubrutinib Dosing for B-Cell Malignancies at a Single Center

Mohit Narang, Courtney Horn, Edward Lee

Clinical Medicine Insights: Oncology

Select article: Synergistic Effects of Zanubrutinib Combined With CD19 CAR-T Cells in Raji Cells in Vitro and in Vivo

Open access

Research article

First published 2022

Synergistic Effects of Zanubrutinib Combined With CD19 CAR-T Cells in Raji Cells in Vitro and in Vivo

Xiupeng Ye, Meijing Liu, Cuicui Lv [...]

Technology in Cancer Research & Treatment

Select article: Quantitative evaluation and pharmacokinetic characteristics of the irreversible BTK inhibitor zanubrutinib in mouse plasma using LC-MS/MS

Retricted access

Research article

First published 2022-8

Quantitative evaluation and pharmacokinetic characteristics of the irreversible BTK inhibitor zanubrutinib in mouse plasma using LC-MS/MS

Kai Cheng, Junsong Wei, Jianrong Kou [...]

European Journal of Mass Spectrometry

Select article: Efficacy of zanubrutinib versus acalabrutinib for relapsed or refractory chronic lymphocytic leukemia (R/R CLL): a matching-adjusted indirect comparison (MAIC)

Open access

Brief report

First published 2025

Efficacy of zanubrutinib versus acalabrutinib for relapsed or refractory chronic lymphocytic leukemia (R/R CLL): a matching-adjusted indirect comparison (MAIC)

Mazyar Shadman, Jennifer R. Brown, Rhys Williams [...]

Therapeutic Advances in Medical Oncology

Select article: Zanubrutinib for high-risk Waldenström macroglobulinemia with complex karyotype and hyperleukocytosis: A case report and literature review

Open access

Case report

First published 2025

Zanubrutinib for high-risk Waldenström macroglobulinemia with complex karyotype and hyperleukocytosis: A case report and literature review

Jiale Chen, Jieyi Zhou, Chengyang Xu [...]

Sage Open Medical Case Reports

Select article: Current and novel BTK inhibitors in Waldenström’s macroglobulinemia

Open access

Research article

First published 2021

Current and novel BTK inhibitors in Waldenström’s macroglobulinemia

Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Despina Fotiou [...]

Therapeutic Advances in Hematology

Select article: Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia: A review

Retricted access

Review article

First published 2021-12

Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia: A review

Donald C Moore

Journal of Oncology Pharmacy Practice

1
2
10 / page

Article type

Publication date

Subjects

Access